Physician profile
Collen Calvey
NPI 1477787596
$1,675.43
in general payments reported to CMS, 2019-2025
20 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $58.05 · 2021: $40.94 · 2022: $187 · 2023: $92.68 · 2024: $568 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $402.02 | 2024 | |
| Integra Lifesciences Corporation | $376.83 | 2019 | |
| Amgen INC. | $238.60 | 2020-2025 | Evenity, Prolia |
| Rock Medical Orthopedics, INC. | $140.92 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $83.33 | 2021-2023 | Xiaflex |
| Radius Health, INC. | $81.72 | 2019-2025 | Tymlos |
| Pacira Pharmaceuticals Incorporated | $70.73 | 2024-2025 | Exparel, Zilretta |
| Davol INC. | $38.28 | 2025 | Arista |
| Endo USA, INC. | $37.13 | 2025 | Xiaflex |
| Vertex Pharmaceuticals Incorporated | $33.19 | 2025 | |
| Axogen | $31.24 | 2025 | |
| Organogenesis INC. | $23.20 | 2025 | Puraply Wound Matrix |
| Breg, INC | $18.75 | 2019 | |
| Vericel Corporation | $17.49 | 2024 | Maci |
| Si-Bone, INC. | $17.34 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $16.05 | 2023 | |
| Bioventus LLC | $12.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.25 | 2019 | |
| Merck Sharp & Dohme LLC | $11.76 | 2022 | |
| Pacira Therapeutics, INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collen Calvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.